FINWIRES · TerminalLIVE
FINWIRES

EMEA Oil Update: Crude Rises as Stalled US-Iran Talks Keep Hormuz Flows Constrained

By

-- EMEA crude futures climbed in after-hours trading on Monday, as stalled peace talks between the US and Iran continued to disrupt flows through the Strait of Hormuz, stoking concerns over a tightening global supply outlook.

Brent crude futures rose by 3.15% to $108.65 per barrel, while Murban oil futures were up 0.29% to $103.89/bbl.

Soojin Kim, research analyst at MUFG, said crude climbed again as stalled US-Iran peace efforts and the continued closure of the Hormuz prolonged one of the biggest energy supply disruptions in recent history.

German Chancellor Friedrich Merz reportedly said on Monday that the US is being "humiliated" by the Iranian leadership as President Trump is failing to negotiate an end to the ongoing Middle East conflict.

Speaking to a group of students at a secondary school in western Germany, Merz said the US doesn't have a clear exit strategy to its conflict with Iran, adding that an "entire nation is being humiliated by the Iranian leadership, particularly by these so-called Revolutionary Guards."

Over the weekend, Trump canceled a planned trip by US peace envoy Steve Witkoff and Jared Kushner to Pakistan, which is mediating the peace talks, while Iran said it won't negotiate if it's being threatened.

Iran's Foreign Minister, Abbas Araghchi, met Russian President Vladimir Putin in Moscow on Monday to discuss the conflict, as negotiations between the sides appear to have stalled.

Araghchi's trip follows a weekend of talks in Pakistan and Oman, which have both acted as mediators in the negotiations between Tehran and Washington.

"The lack of progress means the market is tightening every day, requiring oil prices to reprice at higher levels," ING strategists said, adding that there is little alternative to fill a about 13 million b/d shortfall.

Putin reportedly told Araghchi that Russia would "do everything that serves your interests, the interests of all the people of the region, so that peace can be achieved as soon as possible".

On Monday, Oman also called for diplomacy to ensure freedom of navigation in the Hormuz.

"We recognize our shared responsibility to the international community and the urgent humanitarian need to free the seafarers held for far too long. Much diplomacy is required and practical solutions to ensure lasting freedom of navigation," Badr al-Busaidi, Oman's Foreign Minister, said in a post on X.

The diplomatic push comes as the US Central Command said its forces were continuing to implement the blockade, preventing vessels from entering or leaving Iranian waters. "American forces have directed 38 ships to turn around, or return to port," CENTCOM said in a post on X Sunday.

On the supply front, Kpler said Europe's refining system is under strain as a shift towards lighter crude slates reduces vacuum gasoil production, a key feedstock for hydrocrackers.

"Supply disruptions in the Middle East and competition from Asia have curtailed access to medium sour grades, tightening the pool of distillate-rich barrels," Kpler analysts said on Monday.

Related Articles

Research

Research Alert: Bio: Q1 Results Above Estimates Despite Meaningful Sales/margin Compression

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:BIO delivered Q1 results showing pressure across both segments, with revenue of $592.1M growing 1.1% Y/Y (~$3M above consensus) but declining 4.2% currency neutral. Adjusted EPS of $1.89 fell 25.6% Y/Y yet beat consensus by $0.10, while operating margin deteriorated 420 bps to 6.6% from 10.8% in the prior year. Both Life Science and Clinical Diagnostics segments experienced currency neutral declines due to ongoing academia weakness and Middle East conflicts. Management lowered 2026 guidance, expecting currency neutral revenue of -3.0% to +0.5% growth (down from +0.5% to +1.5%) and operating margin of 10.0%-12.0% (vs. prior 12.0%-12.5%). Despite operational headwinds, BIO maintained strong cash generation with $78.1M in FCF and repurchased ~176K shares. The company's balance sheet remains healthy, with $1.56B in cash and short-term investments, providing financial flexibility amid challenging market conditions, in our view.

$BIO
Asia

ResMed Posts Higher Fiscal Q3 Non-GAAP Earnings, Revenue

ResMed (ASX:RMD) reported Friday fiscal third-quarter non-GAAP earnings of $2.86 per share, up from $2.37 a year earlier.Analysts polled by FactSet expected earnings of $2.80.Revenue for the three months ended March 31 was $1.43 billion, compared with $1.29 billion a year earlier. Analysts surveyed by FactSet expected $1.42 billion.The company expects its fiscal 2026 non-GAAP gross margin to be between 62% and 63%.The board declared a quarterly dividend of $0.60 per share, up from $0.53 a year earlier, payable June 18 to shareholders on record as of May 14.

$ASX:RMD
Research

Research Alert: Gddy: Strong Profitability Metrics Offset By Continued Revenue Headwinds

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:GDDY posted Q1 2026 revenue of $1.2B (+6%), in line with consensus, with EPS of $1.60 beating estimates of $1.52 despite booking deceleration to +2.7% from +5% in Q4. A&C segment growth of +11.6% to $498M showed resilience but continued moderating, while Core Platform remained sluggish at +2.8%. We view booking weakness as concerning given competitive pressures and small business spending constraints that raise questions about growth sustainability. Management reaffirmed 2026 revenue guidance of $5.195B-$5.275B (~6% growth), reflecting limited visibility into booking improvement. However, we see encouraging AI monetization signs with ARPU growth of +9.3% to $246 and Airo AI Builder achieving multi-million dollar annualized bookings within weeks of beta launch. We believe GDDY's impressive margin expansion with NEBITDA margins reaching 32.6% (+210 bps) demonstrates operational discipline, though sustaining A&C growth above 10% remains critical for investor confidence.

$GDDY